Therapeutic Drug Monitoring Market To Reach $2.32 Billion By 2030

Therapeutic Drug Monitoring Market Growth & Trends

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

 Request a free sample copy or view report summary: Therapeutic Drug Monitoring Market Report

Therapeutic Drug Monitoring Market Report Highlights

• The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.

• The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.

• The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.

• The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Therapeutic Drug Monitoring Market Segmentation

Grand View Research has segmented the global therapeutic drug monitoring market report based on product, drug class, end use, and region:

Therapeutic Drug Monitoring Product Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment

  • Immunoassay Analyzers

  • Clinical Chemistry Analyzers

  • Chromatography & MS Detectors

• Consumables

Therapeutic Drug Monitoring Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• Antiarrhythmic Drugs

• Immunosuppressants

• Antiepileptic Drugs

• Others

Therapeutic Drug Monitoring End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic Centers

• Others

Therapeutic Drug Monitoring Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Therapeutic Drug Monitoring Market

• Abbott

• ALPCO

• Beckman Coulter, Inc

• Bio-Rad Laboratories, Inc

• Thermo Fisher Scientific Inc.

• Chromsystems Instruments & Chemicals GmbH

• F.Hoffmann-La Roche Ltd.

• Randox laboratories Ltd

• Siemens Healthineers AG.

• biomérieux, Inc.